Agid, O, Arenovich, T, Sajeev, G, Zipursky, RB, Kapur, S, Foussias, G, Remington, G (2011). An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. Journal of Clinical Psychiatry
Andreasen, NC, Carpenter, WT, Kane, JM, Lasser, RA, Marder, SR, Weinberger, DR (2005). Remission in schizophrenia: proposed criteria and rationale for consensus. American Journal of Psychiatry
Buchanan, RW, Kreyenbuhl, J, Kelly, DL, Noel, JM, Boggs, DL, Fischer, BA, Himelhoch, S, Fang, B, Peterson, E, Aquino, PR, Keller, W (2010). The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophrenia Bulletin
Demjaha, A, Egerton, A, Murray, RM, Kapur, S, Howes, OD, Stone, JM, McGuire, PK (2014). Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function. Biological Psychiatry
Demjaha, A, Morgan, K, Morgan, C, Landau, S, Dean, K, Reichenberg, A, Sham, P, Fearon, P, Hutchinson, G, Jones, PB, Murray, RM, Dazzan, P (2009). Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11?
Demjaha, A, Murray, RM, McGuire, PK, Kapur, S, Howes, OD (2012). Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. American Journal of Psychiatry
Dreher, JC, Meyer-Lindenberg, A, Kohn, P, Berman, KF (2008). Age-related changes in midbrain dopaminergic regulation of the human reward system. Proceedings of the National Academy of Sciences
Gallego, JA, Robinson, DG, Sevy, SM, Napolitano, B, McCormack, J, Lesser, ML, Kane, JM (2011). Time to treatment response in first episode schizophrenia: should acute treatment trials last several months?
Journal of Clinical Psychiatry
Gardner, DM, Murphy, A, O'Donnell, H, Centorrino, F, Baldessarini, RJ (2010). International consensus study of antipsychotic dosing. American Journal of Psychiatry
Harrell, FE Jr. (2015). Regression Modeling Strategies: with Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis, 2nd edn.
Springer-Verlag: New York.
Harrison, G, Hopper, K, Craig, T, Laska, E, Siegel, C, Wanderling, J, Dube, KC, Ganev, K, Giel, R, an der Heiden, W, Holmberg, SK, Janca, A, Lee, PW, León, CA, Malhotra, S, Marsella, AJ, Nakane, Y, Sartorius, N, Shen, Y, Skoda, C, Thara, R, Tsirkin, SJ, Varma, VK, Walsh, D, Wiersma, D (2001). Recovery from psychotic illness: a 15- and 25-year international follow-up study. British Journal of Psychiatry
Hastie, T, Tibshirani, R, Friedman, J (2009). The Elements of Statistical Learning, 2nd edn. Springer: New York.
Howes, OD, McCutcheon, R, Agid, O, de Bartolomeis, A, van Beveren, NJ, Birnbaum, ML, Bloomfield, MA, Bressan, RA, Buchanan, RW, Carpenter, WT, Castle, DJ, Citrome, L, Daskalakis, ZJ, Davidson, M, Drake, RJ, Dursun, S, Ebdrup, BH, Elkis, H, Falkai, P, Fleischacker, WW, Gadelha, A, Gaughran, F, Glenthøj, BY, Graff-Guerrero, A, Hallak, JE, Honer, WG, Kennedy, J, Kinon, BJ, Lawrie, SM, Lee, J, Leweke, FM, MacCabe, JH, McNabb, CB, Meltzer, H, Möller, HJ, Nakajima, S, Pantelis, C, Reis Marques, T, Remington, G, Rossell, SL, Russell, BR, Siu, CO, Suzuki, T, Sommer, IE, Taylor, D, Thomas, N, Üçok, A, Umbricht, D, Walters, JT, Kane, J, Correll, CU (2016). Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology. American Journal of Psychiatry. doi:10.1176/appi.ajp.2016.16050503.
Kane, J, Honigfeld, G, Singer, J, Meltzer, H (1988). Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Archives of General Psychiatry
Kolakowska, T, Williams, A, Ardern, M, Reveley, M, Jambor, K, Gelder, M, Mandelbrote, B (1985). Schizophrenia with good and poor outcome. I: early clinical features, response to neuroleptics and signs of organic dysfunction. British Journal of Psychiatry
Lally, J, Ajnakina, O, Di Forti, M, Trotta, A, Demjaha, A, Kolliakou, A, Mondelli, V, Marques, TR, Pariante, C, Dazzan, P, Shergil, SS, Howes, OD, David, AS, MacCabe, JH, Gaughran, F, Murray, RM (2016). Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses. Psychological Medicine
Levine, SZ, Rabinowitz, J, Faries, D, Lawson, AH, Ascher-Svanum, H (2012). Treatment response trajectories and antipsychotic medications: examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial. Schizophrenia Research
Lieberman, J, Jody, D, Geisler, S, Alvir, J, Loebel, A, Szymanski, S, Woerner, M, Borenstein, M (1993). Time course and biologic correlates of treatment response in first-episode schizophrenia. Archives of General Psychiatry
Loebel, AD, Lieberman, JA, Alvir, JM, Mayerhoff, DI, Geisler, SH, Szymanski, SR (1992). Duration of psychosis and outcome in first-episode schizophrenia. American Journal of Psychiatry
MacMillan, JF, Crow, TJ, Johnson, AL, Johnstone, EC (1986). Short-term outcome in trial entrants and trial eligible patients. British Journal of Psychiatry
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry
McCreadie, RG, Wiles, D, Grant, S, Crockett, GT, Mahmood, Z, Livingston, MG, Watt, JA, Greene, JG, Kershaw, PW, Todd, NA (1989). The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group. Acta Psychiatrica Scandinavica
Meltzer, HY (1997). Treatment-resistant schizophrenia – the role of clozapine. Current Medical Research and Opinion
Meltzer, HY, Rabinowitz, J, Lee, MA, Cola, PA, Ranjan, R, Findling, RL, Thompson, PA (1997). Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. American Journal of Psychiatry
Morgan, C, Lappin, J, Heslin, M, Donoghue, K, Lomas, B, Reininghaus, U, Onyejiaka, A, Croudace, T, Jones, PB, Murray, RM, Fearon, P, Doody, GA, Dazzan, P (2014). Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychological Medicine
National Institute for Health and Care Excellence (NICE) (2014). Psychosis and Schizophrenia in Adults: Treatment and Management (Clinical Guideline 178). Royal College of Psychiatrists: London.
Patel, MX, Bishara, D, Jayakumar, S, Zalewska, K, Shiers, D, Crawford, MJ, Cooper, SJ (2014). Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales. European Neuropsychopharmacology
Team, R Core (2014). R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria.
Robinson, DG, Woerner, MG, Alvir, JM, Geisler, S, Koreen, A, Sheitman, B, Chakos, M, Mayerhoff, D, Bilder, R, Goldman, R, Lieberman JA (1999). Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder. American Journal of Psychiatry
Schennach, R, Riedel, M, Musil, R, Moller, HJ (2012). Treatment response in first-episode schizophrenia. Clinical Psychopharmacology and Neuroscience
Sheitman, B, Lieberman, J (1998). The natural history and pathophysiology of treatment resistant schizophrenia. Journal of Psychiatric Research
Susser, E, Finnerty, M, Mojtabai, R, Yale, S, Conover, S, Goetz, R, Amador, X (2000). Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophrenia Research
World Health Organization (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.
World Health Organization (1994). Schedules for Clinical Assessment in Neuropsychiatry Version 2: Manual. World Health Organization, Division of Mental Health: Geneva.